Observation of clinical efficacy of Alprostadil E1 and Tanreqing in acute icterichepatitis.
-
摘要: 目的观察前列腺素E1联合痰热清注射液治疗急性黄疸型肝炎疗效。方法将156例急性黄疸型肝炎患者分为2组,治疗组84例在常规治疗的基础上应用前列腺素E1和痰热清注射液,对照组72例患者在常规治疗的基础上给予茵栀黄注射液。疗程为1个月。结果治疗结束时治疗组临床症状、肝功能指标等明显好于对照组(P<0.05)。结论前列腺素E1联合痰热清注射液能有效治疗急性黄疸型肝炎,安全性好。Abstract: Objective To evaluate the clinical efficacy of Alprostadil E1 and Tanreqing in acute icterichepatitis.Methods 156 acute icterichepatitis were randomly divided into treat group and control group.Patients in treat group (84) were treated with Alprostadil E1 and Tanreqing for one month.However, patients in control group (72) with Yinzhihuang for one month.Patients in both groups were treated with conventional treatment.Results Clinical symptoms and liver function of the patients in treat group were better than those in control group (P<0.05) .When the therapy was completed.Conclusions Alprostadil E1 and Tanreqing is effective and safe in acute icterichepatitis.
-
Key words:
- acute icterichepatitis /
- Alprostadil E1 /
- Tanreqing
-
[1]中华医学会.病毒性肝炎的防治方案.中华传染病杂志, 2001, 19∶56-62. [2] 王言飞, 刘玉芝, 等.凯西莱联合前列腺素E1慢性肝炎肝硬化疗效观察[J].中华消化病基础与临床, 2006, 4, (7) ∶26. [3]蒋氏复, 沙媪华.前列腺素E1对肝硬化门静脉高压影响的临床研究[J].临床肝胆病杂志, 1998, 14 (1) ∶48. [4]樊英诚.黑熊胆粉治疗慢性乙肝并胆囊炎30例[J].新消化病杂志, 1996, 4 (7) ∶420. [5]康国治, 潘晓明, 等.复方熊胆粉防治胆石病的药效学研究[J].中国中医药科技, 1996, 3 (5) ∶20. [6]邓道伟.痰热清联合凯西莱治疗重型肝炎临床观察[J].中国中医急症, 2006, 15 (10) ∶1090. [7]郑文艳, 杨鲜萍, 张传才.复方甘草甜素联合痰热清注射液治疗急性黄疸型肝炎30例临床观察[J].内蒙古医学杂志, 2007, 39 (6) ∶736. [8]范红顺, 李德昌, 等.痰热清与甘利欣注射液联合治疗病毒性肝炎高胆红素血症48例疗效观察[J].实用医技杂志, 2007, 14 (3) ∶310.
本文二维码
计量
- 文章访问数: 2178
- HTML全文浏览量: 10
- PDF下载量: 698
- 被引次数: 0